Keywords
Lepromatous leprosy
Mycobacterium leprae
Elderly
How to Cite
Abstract
Introduction: leprosy is an endemic disease in Brazil, ranking second worldwide for the number of new cases diagnosed yearly. However, late diagnosis of this disease is still common. Objective: to alert health professionals to the importance of recognizing the insidious signs of leprosy, both clinical and histopathological, even in the presence of other, more apparent alterations. Presentation and discussion of the case: a man with skin lesions suggestive of squamous cell carcinoma. On histological examination, besides the carcinoma, there were aggregates of foamy macrophages full of acidfast bacilli compatible with lepromatous leprosy. A more detailed physical examination by a multidisciplinary team from a national reference center also revealed skin with a diffuse infiltrated appearance and supraciliary madarosis, alterations not noticed in the first evaluation at another service. Final considerations: this case can help clinical professionals and pathologists pay attention to skin alterations that can make it challenging to diagnose leprosy, especially in endemic regions, to enable early diagnosis and reduce the disabilities related to the disease.
References
1. Ministério da Saúde (Brasil). Boletim epidemiológico de hanseníase 2022 [Internet]. Brasília: Ministério da Saúde; 2022. [acesso em 15 jun. 2023]. Disponível em: https://antigo.aids.gov.br/pt-br/pub/2022/boletimepidemiologico-de-hanseniase-2022.
2. Han XY, Seo YH, Sizer KC, Schoberle T, May GS, Spencer JS, et al. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol. 2008 Dec;130(6):856-64. doi: https://doi.org/10.1309/AJCPP72FJZZRRVMM.
3. World Health Organization. Towards zero leprosy. Global leprosy (Hansen’s Disease) strategy 2021–2030 [Internet]. Índia: World Health Organization; 2021. [cited 2023 May 18]. Available from: https://www.who.int/publications/i/item/9789290228509.
4. Llamas-Velasco M, Pérez-Muñoz N, Rozas-Muñoz E, Ballester R, Posada R, Figueras MF. Approach to the so-called “Invisible Dermatosis”: when subtle histopathological findings guide diagnosis. Am J Dermatopathol[Internet]. 2023 Dec[cited 2023 May 18];45(12):801-11. Available from: https://www.binasss.sa.cr/bibliotecas/bhm/dic23/4.pdf.
5. Kundakci N, Erdem C. Leprosy: a great imitator. Clin Dermatol. 2019 May;37(3):200-12. doi: https://doi.org/10.1016/j.clindermatol.2019.01.002.
6. Kligman AM. The invisible dermatoses. Arch Dermatol. 1991 Sep;127(9):1375-82. doi: https://doi.org/10.1001/archderm.1991.01680080111013.
7. Alrehaili J. Leprosy classification, clinical features, epidemiology, and host immunological responses: failure of eradication in 2023. Cureus. 2023;15(9): e44767. doi: https://doi.org/10.7759/cureus.44767.
8. Massone C. Histopathology of the skin. In: Enrico Nunzi, Cesare Massone, editors. Leprosy [Internet]. Milano: Springer Milan; 2012. p. 115-36. [cited 2023 Feb 18]. Available from: http://link.springer.com/10.1007/978-88-470-2376-5_12.
9. Brownstein MH, Rabinowitz AD. The invisible dermatoses. J Am Acad Dermatol. 1983 Apr;8(4):579-88.
10. Soares CT. Histopathological diagnosis of leprosy [Internet]. Sharjah: Bentham Science Publishers; 2021. Regression and Relapse; p. 180-221. [cited 2023 Feb 18]. Available from: https://www.eurekaselect.com/193161/volume/1.
11. Di Nardo L, Pellegrini C, Di Stefani A, Del Regno L, Sollena P, Piccerillo A, et al. Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies. J Eur Acad Dermatol Venereol. 2020 May;34(5):932-41. doi: https://doi.org/10.1111/jdv.16098.
12. Victoria F, Pribadi S. Meta-analysis: squamous cell carcinoma cases arising from morbus hansen in Dr. Sitanala Central Hospital (2011-2021). Jurnal Rekonstruksi dan Estetik. 2023 Jun 1[cited 2023 Feb 18];8(1):39-46. Available from: https://e-journal.unair.ac.id/JRE/article/view/37048/24851.
13. Braghiroli CS, Parise-Fortes MR, Marques MEA, Lastória JC. Lepromatous leprosy, melanoma, and basal cell carcinoma: clinical-histopathologic association. An Bras Dermatol. 2019 Sep 1;94(5):586-9. doi: https://doi.org/10.1016/j.abd.2019.09.008.
14. Ratoosh SL, Cohen PR, Troncoso P. Cutaneous malignancy and leprosy report of a patient with Mycobacterium leprae and basal cell carcinoma concurrently present in the same lesion. J Dermatol Surg Oncol. 1994 Sep;20(9):613-8. doi: https://doi.org/10.1111/j.1524-4725.1994.tb00154.x.
15. Mysore V. Invisible dermatoses. Indian J Dermatol Venereol Leprol. 2010;76(3):239. doi: https://doi.org/10.4103/0378-6323.62962.
16. Tomasini C, Michelerio A. Invisible dermatoses: clues and pitfalls to diagnosis. Diagn Histopathol. 2018 Aug;24(8):320-37. doi: https:/doi.org/10.1016/j.mpdhp.2018.07.001.
17. Yawalkar SJ. Leprosy for medical practitioners and paramedical workers. 7th ed. Basle: Novertis Foudation for Sustainable Development; 2002. 132 p.
18. Britton WJ, Lockwood DN. Leprosy. The Lancet. 2004 Apr 10;363(9416):1209-19. doi: https://doi.org/10.1016/S0140-6736(04)15952-7.
19. Massone C, Belachew WA, Schettini A. Histopathology of the lepromatous skin biopsy. Clin Dermatol. 2015 Jan;33(1):38-45. doi: https://doi.org/10.1016/j.clindermatol.2014.10.003.
20. Chang ALS, Wong JW, Endo JO, Norman RA. Geriatric dermatology review: major changes in skin function in older patients and their contribution to common clinical challenges. J Am Med Dir Assoc. 2013 Oct;14(10):724-30. doi: https://doi.org/10.1016/j.jamda.2013.02.014.
21. Puizina-Ivić N. Skin aging. Acta Dermatovenerol Alp Pannonica Adriat. 2008 Jun;17(2):47-54.
22. Kusumaningrum N, Purnamawati S, Winarni DRA, Soebono H. Lepromatous leprosy mimicking systemic lupus erithematosus: a case report. Med J Indonesia. 2019 May 8;28(1):77-81.
23. Richardus JH, Smith TC. Squamous cell carcinoma in plantar ulcers in leprosy. A case control study. Lepr Rev. 1993;64(3):170-4. doi: https://doi.org/10.5935/0305-7518.19930031.
24. Kikuchi I, Nogami R. Squamous-cell carcinoma arising in solar keratosis of a leprosy patient: relationship with positive skin smear
examination. J Dermatol. 1991 Sep 9;18(9):540-4. doi: https://doi.org/10.1111/j.1346-8138.1991.tb03130.x.
25. Bottomley MJ, Thomson J, Harwood C, Leigh I. The role of the immune system in cutaneous squamous cell carcinoma. Int J Mol Sci. 2019 Apr 24;20(8):2009. doi: https://doi.org/10.3390/ijms20082009.
26. Alhumidi A, Alshamlan N, Alfaraidi M, Mohajer K. Invisible dermatosis, diagnostic discrepancy between the general pathologist and dermatopathologist. J Cutan Pathol. 2019 Dec 16;46(12):905-12. doi: https://doi.org/10.1111/cup.13554.
27. Goulart IMB, Goulart LR. Leprosy: diagnostic and control challenges for a worldwide disease. Arch Dermatol Res [Internet]. 2008 Jul 7;300(6):269-90. doi: https://doi.org/10.1007/s00403-008-0857-y.
28. Ministério da Saúde (Brasil). Nota Técnica Conjunta nº 9/2021 – CGDE/DCCI/SVS/MS. Aborda sobre atenção especial às pessoas idosas acometidas pela hanseníase. Brasília; 2021. [citado em 25 set. 2023]. Disponível em: https://antigo.aids.gov.br/pt-br/legislacao/nota-tecnica-no-92021-cgdedccisvsms.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Hugo Hatanaka, Bruno de Carvalho Dornelas, Pauline Dias Soares Girardi, Caio Oliveira Sena, Marcelo Campos Rocha, Isabela Maria Bernardes Goulart
Downloads
